Company intelligence / Profile preview

Qualia Oto

Dallas, Texas, United States

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Qualia Oto has demonstrated the technical feasibility of flexible, high-channel-count, matrix-addressed cochlear implant electrode arrays in preliminary studies and is preparing to validate its devices in animal models, with results published in peer-reviewed journals and recognized federal grant milestones.

Therapeutic areas: Neurology
Modalities: DevicePolymer-based deviceDrug delivery device
Industry: Implantable Medical Devices

Partnerships

University of Texas at DallasAsia Pacific Symposium sponsors: Advanced Bionics, Cochlear, MED-EL (conference affiliations)

Beyond the preview

Go deeper on Qualia Oto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qualia Oto.

Explore the full profile